Literature DB >> 11306073

Characterization of the glutathione binding site of aldose reductase.

K V Ramana1, B L Dixit, S Srivastava, A Bhatnagar, G K Balendiran, S J Watowich, J M Petrash, S K Srivastava.   

Abstract

Despite extensive investigations, the physiological role of the polyol pathway enzyme-aldose reductase (AR) remains obscure. While the enzyme reduces glucose in vivo and in vitro, kinetic and structural studies indicate inefficient carbohydrate binding to the active site of the enzyme. The active site is lined by hydrophobic residues and appears more compatible with the binding of medium- to long-chain aliphatic aldehydes or hydrophobic aromatic aldehydes. In addition, our recent studies show that glutathione (GS) conjugates are also reduced efficiently by the enzyme. For instance, the GS conjugate of acrolein is reduced with a catalytic efficiency 1000-fold higher than the parent aldehyde, indicating specific recognition of glutathione by the active site residues of AR. An increase in the catalytic efficiency upon glutathiolation was also observed with trans-2-nonenal, trans-2-hexenal and trans, trans-2,4-decadienal, establishing that enhancement of catalytic efficiency was specifically due to the glutathione backbone and not specific to the aldehyde. Structure-activity relationships with substitution or deletion of amino acids of GSH indicated specific interactions of the active site with gamma-Glu1 and Cys of GSH. Molecular modeling revealed that the glutathione-propanal conjugate could bind in two distinct orientations. In orientation 1, gamma-Glu1 of the conjugate interacts with Trp20, Lys21 and Val47, and Gly3 interacts with Ser302 and Leu301, whereas in orientation 2, the molecule is inverted with gamma-Glu1 interacting with Ser302, and Leu301. Taken together, these data suggest that glutathiolation of aldehydes enhances their compatibility with the AR active site, which may be of physiological significance in detoxification of endogenous and xenobiotic aldehydes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306073     DOI: 10.1016/s0009-2797(00)00297-0

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.

Authors:  Rachel J Keith; Petra Haberzettl; Elena Vladykovskaya; Bradford G Hill; Karin Kaiserova; Sanjay Srivastava; Oleg Barski; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2008-11-11       Impact factor: 5.192

Review 2.  Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.

Authors:  Satish K Srivastava; Umesh C S Yadav; Aramati B M Reddy; Ashish Saxena; Ravinder Tammali; Mohammad Shoeb; Naseem H Ansari; Aruni Bhatnagar; Mark J Petrash; Sanjay Srivastava; Kota V Ramana
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

3.  ALDOSE REDUCTASE: New Insights for an Old Enzyme.

Authors:  Kota V Ramana
Journal:  Biomol Concepts       Date:  2011-04-01

4.  Protection of HepG2 cells against acrolein toxicity by 2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide via glutathione-mediated mechanism.

Authors:  Halley Shah; Adam M Speen; Christina Saunders; Elizabeth A S Brooke; Palanisamy Nallasamy; Hong Zhu; Y Robert Li; Zhenquan Jia
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-11

Review 5.  Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes.

Authors:  Umesh C S Yadav; Kota V Ramana
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.